KLK3 and renal cell carcinoma: The literature demonstrates the therapeutic and prognostic value of biomarkers involved in the bio-molecular mechanism of urothelial carcinoma and other urinary tract tumors like CXR2 and CXR3 in renal cell carcinoma and prostate-specific antigen (PSA) in prostatic adenocarcinoma (6-11).